Dr. Barlam is the Chief of the Section of Infectious Diseases and the Director of Antimicrobial Stewardship for the Boston Medical Center. She has close to 30 years’ experience directing antimicrobial stewardship programs. Her research is focused on understanding factors that influence antimicrobial prescribing, and the implementation and impact of stewardship interventions. She has also led public policy initiatives to reduce inappropriate use of antimicrobials in food animals and served on a national task force to improve antimicrobial use in companion animals. She is the chair of a national committee on antimicrobial stewardship education and implementation.
Diversity, Equity, Inclusion and Accessibility
Diversity, equity, inclusion, and accessibility (DEIA) are central to how I approach my role as a clinician, researcher and leader in infectious diseases.
In clinical practice, I have sought settings where diverse patient populations are served and strived to provide culturally sensitive care. This is a major reason why I practice at Boston Medical Center.
As a researcher, I have incorporated examination of racial, ethnic and sociodemographic inequities in antibiotic prescribing into my projects. I currently co-mentor a junior faculty member on a project examining racial differences in antibiotic choice and patient outcomes using a national dataset. I am committed to mentoring trainees and faculty from underrepresented groups and to researching ways to reduce inequities within infectious diseases.
As chief of the ID Section, I have sought diverse candidates for recruitment and doubled faculty who are members of groups underrepresented in medicine. I have supported our DEIA efforts such as our ID-based Racial Justice group and have participated in all the training on bias and microaggressions offered here at BU. As Chair of the Antibiotic Stewardship Committee for my professional organization, Society for Healthcare Epidemiology of America (SHEA), I convened a workgroup to examine DEIA in the hospital epidemiology / antibiotic stewardship workforce as well as examining any bias in the care we provide. The initiatives of my committee helped set the 5-year strategic plan for SHEA as whole.
Boston University Chobanian & Avedisian School of Medicine
04/01/2019 - 03/31/2023 (Multi-PI)
PI: Tamar F BarlamUniversity of Antwerp European Commission
Evaluating the Effectivness of Alternative Implementation Strategies for Antibiotic Stewardship
05/01/2017 - 04/30/2021 (PI)
Univ of Utah DHHS
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 46 results.
Dhanani M, Goodrich C, Weinberg J, Acuna-Villaorduna C, Barlam TF. Antibiotic therapy completion for injection drug use-associated infective endocarditis at a center with routine addiction medicine consultation: a retrospective cohort study. BMC Infect Dis. 2022 Feb 05; 22(1):128.View Related Profiles. PMID: 35123439; PMCID: PMC8818134; DOI: 10.1186/s12879-022-07122-x;
Brady KJS, Barlam TF, Trockel MT, Ni P, Sheldrick RC, Schneider JI, Rowe SG, Kazis LE. Clinician Distress and Inappropriate Antibiotic Prescribing for Acute Respiratory Tract Infections: A Retrospective Cohort Study. Jt Comm J Qual Patient Saf. 2022 May; 48(5):287-297.View Related Profiles. PMID: 35489803
Livorsi DJ, Drainoni ML, Reisinger HS, Nanda N, McGregor JC, Barlam TF, Morris AM, Szymczak JE. Leveraging implementation science to advance antibiotic stewardship practice and research. Infect Control Hosp Epidemiol. 2022 02; 43(2):139-146.View Related Profiles. PMID: 34852212
Heil EL, Bork JT, Abbo LM, Barlam TF, Cosgrove SE, Davis A, Ha DR, Jenkins TC, Kaye KS, Lewis JS, Ortwine JK, Pogue JM, Spivak ES, Stevens MP, Vaezi L, Tamma PD. Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process. Open Forum Infect Dis. 2021 Oct; 8(10):ofab434. PMID: 34738022; PMCID: PMC8561258; DOI: 10.1093/ofid/ofab434;
Barocas JA, Komaromy M, Haidar D, Barlam TF, Orr BL, Miller NS. Assessment of Oropharyngeal Specimens for Discontinuation of Transmission-Based COVID-19 Precautions. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa382.View Related Profiles. PMID: 32964067; PMCID: PMC7494181; DOI: 10.1093/ofid/ofaa382;
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;
Barlam TF, Childs E, Zieminski SA, Meshesha TM, Jones KE, Butler JM, Damschroder LJ, Goetz MB, Madaras-Kelly K, Reardon CM, Samore MH, Shen J, Stenehjem E, Zhang Y, Drainoni ML. Perspectives of Physician and Pharmacist Stewards on Successful Antibiotic Stewardship Program Implementation: A Qualitative Study. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa229.View Related Profiles. PMID: 32704510; PMCID: PMC7367692; DOI: 10.1093/ofid/ofaa229;
Eby JC, Lane MA, Horberg M, Gentry CN, Coffin SE, Ray AJ, Sheridan KR, Bratzler DW, Wheeler D, Sarumi M, Barlam TF, Kim TJ, Rodriguez A, Nahass RG. How Do You Measure Up: Quality Measurement for Improving Patient Care and Establishing the Value of Infectious Diseases Specialists. Clin Infect Dis. 2019 05 17; 68(11):1946-1951. PMID: 30256911
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
Available to Mentor as: (Review Mentor Role Definitions)
Co-Mentor or Peer Mentor
Research / Scholarly Mentor
Contact for Mentoring: